Grifols Deutschland GmbH, headquartered in Frankfurt am Main, operates as a wholly-owned subsidiary of the Grifols S.A. group and is strategically positioned for the German market. The company distributes biological-therapeutic products based on blood plasma in the Biopharma division, as well as reagents and medical instruments in the Diagnostic division. As a central player in the group's European growth strategy, the company primarily supplies clinics and healthcare centers. Its operational activities include the import, export, and trade of products, with supply chain security ensured exclusively through internal group sister companies.
1. die Erlangung der öffentlichen Erlaubnisse und Genehmigungen, die für die Vermarktung und den Vertrieb von biologisch-therapeutischen Produkten auf Blutplasmabasis erforderlich sind, und 2. nach Erhalt der jeweiligen Erlaubnis oder Genehmigung, die Vermarktung und der Vertrieb von biologisch-therapeutischen Produkten auf Blutplasmabasis in dem von der jeweiligen Erlaubnis oder Genehmigung gedeckten Umfang, sowie 3. der Import, Export, Vertrieb und Handel mit Reagenzien, medizinischen Materialien und Instrumenten, die speziell für Laboratorien und Gesundheitszentren bestimmt sind.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 76336 (as of 3 October 2026)
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 76336 (as of 3 October 2026)
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 76336 (as of 3 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 76336 (as of 3 October 2026)
Sign in to view detailed salary and cost trends.
